Gene · 22806
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AIOLOS-Associated Inborn Errors of Immunity. | J Clin Immunol | 2024 | 38773004 | PubTator, text mining | PubMed |
| Identification of disease-specific genes related to immune infiltration in nonalcoholic steatohepatitis using machine learning algorithms. | Medicine (Baltimore) | 2024 | 38758850 | PubTator, text mining | PubMed |
| Identification and Functional Analysis of a de novo IKZF3 Mutation in a Pediatric Patient with Combined Immunodeficiency. | J Clin Immunol | 2024 | 38758229 | PubTator, text mining | PubMed |
| MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance. | Clin Cancer Res | 2024 | 38723281 | PubTator, text mining | PubMed |
| Repression of developmental transcription factor networks triggers aging-associated gene expression in human glial progenitor cells. | Nat Commun | 2024 | 38719882 | PubTator, text mining | PubMed |
| Inhibitors to degraders: Changing paradigm in drug discovery. | iScience | 2024 | 38646175 | PubTator, text mining | PubMed |
| Shared genetic architecture between autoimmune disorders and B-cell acute lymphoblastic leukemia: insights from large-scale genome-wide cross-trait analysis. | BMC Med | 2024 | 38616254 | PubTator, text mining | PubMed |
| Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma. | Cancers (Basel) | 2024 | 38610997 | PubTator, text mining | PubMed |
| Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells. | bioRxiv | 2024 | 38559242 | PubTator, text mining | PubMed |
| Analysis of Primary Chronic Lymphocytic Leukemia Cells' Signaling Pathways. | Biomedicines | 2024 | 38540136 | PubTator, text mining | PubMed |
| Mezigdomide-A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma. | Cancers (Basel) | 2024 | 38539501 | PubTator, text mining | PubMed |
| Multizentrische, randomisiert-kontrollierte Studien der ACO/AIO/ARO. | Chirurgie (Heidelb) | 2024 | 38507049 | PubTator, text mining | PubMed |
| Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities. | Nat Cell Biol | 2024 | 38379051 | PubTator, text mining | PubMed |
| Expression levels of GSDMB and ORMDL3 are associated with relapsing-remitting multiple sclerosis and IKZF3 rs12946510 variant. | Heliyon | 2024 | 38314276 | PubTator, text mining | PubMed |
| Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies. | J Med Chem | 2024 | 38300987 | PubTator, text mining | PubMed |
| A Rare AIOLOS N160S Variant Causing IEI in Human. | J Clin Immunol | 2024 | 38296893 | PubTator, text mining | PubMed |
| Nuclear and mitochondrial genetic variants associated with mitochondrial DNA copy number. | Sci Rep | 2024 | 38267512 | PubTator, text mining | PubMed |
| HIV Expression in Infected T Cell Clones. | Viruses | 2024 | 38257808 | PubTator, text mining | PubMed |
| Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus. | Int J Mol Sci | 2024 | 38256093 | PubTator, text mining | PubMed |
| IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. | Biomedicines | 2024 | 38255194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22806/papers?page=7